Atherosclerosis

Article	Citations
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES	204
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON	159
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY	157
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES	139
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON	113
Integrative prediction models of gestational diabetes mellitus: Insights from lipidomic profiling	105
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial	100
Quantitative data comparing LDL results produced by lipid ultracentrifugation with those calculated by the Sampson equation	98
Antibody functionalized lipoprotein complexes (LPC) including a repolarizing drug for the targeted therapy of atherosclerosis	97
Browning of perivascular adipose tissue during early atherosclerosis progression: A contrast to clinical atherosclerosis	94
Low residence time of exogeneous HDL is associated with preserved renal function in rats treated with HgCl2 and accumulation of HDL-protein in adipose tissue	85
The effect of PCSK9 inhibitor treatment on plasma proteome in patients with and without familial hypercholesterolemia	80
Modulating atherosclerotic plaque formation by targeting the plasminogen receptor Plg-RKT	76
Sex-specific impact of the COVID-19 pandemic on metabolic syndrome prevalence	71
Lp(a) levels in individuals with metabolic-dysfunction associated steatotic liver disease	70
18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity	68
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease	63
Association of traditional cardiometabolic risk factors with atherosclerotic cardiovascular disease in familial hypercholesterolaemia individuals with severe elevation of LDL-cholesterol	62
Rates of atherosclerotic cardiovascular events and their management in a longitudinal cohort of dermatomyositis patients with skin involvement	57
Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus	56
Anti-endoglin monoclonal antibody inhibits the progression of liver sinusoidal endothelial inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis	55
Noninvasive parameters of myocardial work and diastolic myocardial function in the assessment of heart failure with preserved ejection fraction in patients with postinfarction cardiosclerosis	54
Clinical phenotypes of patients with stable coronary artery disease, with or without concomitant COVID-19, based on left ventricular function and cerebral blood flow	53
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS	53
Doxorubicin promotes atherosclerosis in an apolipoprotein e-deficient mouse model, potentially associated with serpina3n	53

ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY	51
COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL	51
Rabies vaccine induced microangiopathy	50
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia	49
Genetic risk score for human serum lipidome and its association with angiographic coronary artery disease	49
IL-21R blockade reduces atherosclerosis development	46
Antagonism of miR-148a attenuates the progression of atherosclerosis in APOBTGApobec-/-Ldlr+/- mice	45
Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome	43
Comparison of cardiovascular prognosis between triglyceride variability and exposure estimate in diabetic patients	42
The role of systemic inflammation in reducing the elasticity of the main arteries in patients with chronic heart failure in combination with obesity	42
Silencing of PCSK9 by SIRNA-functionalized RHDL as tool to upregulate LDLR expression in hepatocytes	42
Regulation of interleukin 1Β drives endothelial-to-mesenchymal transition of valve endothelial cells in patients with aortic valve sclerosis	40
Effect of high- intensity extremely low frequency magnetic field on the intermediate stage atherosclerotic plaque remodeling: Monitored by histopathology and color doppler ultrasonography	40
TREM2 macrophages in adipose tissue and cardiovascular risk	39
Laser- mediated thermal angioplasty of occluded artery accompanied by disulphonated aluminum phthalocyanine - mediated photodynamic therapy combined with catheter- based ruthenium-106 brachytherapy	39
Size, fatty acid and protein characterization of different populations of extracellular vesicles obtained by sequential centrifugation. An useful tool to dissect their biological properties?	39
Targeted proteomics and the presence of carotid plaques in subjects at low cardiovascular disease risk	38
An upregulation of scube 2 expression in type 2 diabetes mellitus with dyslipidemia	37
Atherosclerosis in Brazil: An ecological study	37
Age- and gender-specific lipid and lipoprotein levels and percentiles from the Thai National Health Examination Survey (NHES-VI) in Thailand	36
Quality of life in older patients with obesity and chronic kidney disease	36
Lipid profile assessment as a factor of diabetic nephropathy progression	35
Reversing the functional- and regenerative capacity of senescent endothelial cells by pharmacological reprogramming	35
The reliability of coronary artery calcium score in symptomatic patients: Questioning the “power of zero”	35
Do triglycerides have an influence on endothelial function detected by Laser Doppler flowmetry?	35
Management of significantly elevated lipoprotein(a) in patients without established ASCVD	34
Assessment of the improvement in perfusion after endovascular intervention by hyperspectral imaging	34
Genome-wide association study on HDL-mediated cholesterol efflux capacity	33
Does the lipoprotein(A) genotype influence the diagnosis of familial hypercholesterolemia?	33
Bioactive lipids and lipoprotein lipase in epicardial adipose tissue from patients with coronary artery disease: Unfolding a missing link	33
Influence of mineral bone disease biomarkers in carotid modeling as a marker of early atherosclerosis in dialysis patients	33
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen general population study	32
The real experience of reaching an extremely low LDL-C level in high risk patients	31
Vulnerable atheromatous plaque stabilization using extracorporeal shock wave- mediated sonoporation therapy- assisted HDL and atorvastatin combination therapy	31
Associations of the fatty acids with the concentration of antioxidant enzymes in the blood in men with coronary heart disease	31
The impact of cholesterol lowering drugs on metabolism and epigenetics	31
Effect of B-mode ultrasound- guided extracorporeal low- level focused sonotherapy on early stage atherosclerosis regression using color doppler ultrasonography and histopathology	31
Tetrahydroxystilbene glycoside attenuates endothelial dysfunction and obesity-associated hypertension in obese rats: The role of omentin-1	30
Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium	30
Aging accelerates atherosclerosis development in C57BL/6 mice upon PCSK9 overexpression	30
Genetic expression and immunofluorescence mapping of NaV1 highlight potential therapeutic targets in anti-inflammatory treatment of aortic valves stenosis	30
Collaboration of clinic and Biobank as an effective model for dyslipidemia research	30
Common perinatal characteristics and adverse obstetric complications leading to overweight in adolescence: Assessment of independent and shared maternal-offspring pathways	30
Coronary computed tomography angiography-derived endothelial shear stress in myocardial bridging	30
Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolemia: Data from three pooled open-label studies	29
Illuminating the full spectrum of APOE variation	29
Caspase 8-dependent inhibition of necroptosis prevents plaque necrotic core formation	29
Influence of low glycemic index diet on inflammatory state and lipid parameters in patients with atherosclerotic coronary artery disease	29
CLINICAL AND GENETIC CHARACTERISTICS OF LATE-ONSET LAL DEFICIENCY IN OMAN	28
Differences in coronary angiographic findings and outcomes between men and postmenopausal women with chest pain	27

Low stenosis low volume carotid artery atherosclerotic plaque for early HI-LLT prescription in first grade cardiovascular prevention	27
Vascular structural changes in diabetes mellitus patients with chronic kidney disease	27
Circulating large extracellular vesicles from STEMI patients contribute to cardiovascular damage	26
Illness perception in patients with familial hypercholesterolemia	25
Compensatory metabolic responses in ChREBP-deficient brown adipose tissue	25
Association between level of depression and coronary heart disease, stroke risk and all-cause and cardiovascular mortality	25
“Early detection of cardiovascular risk factors in women following gestational diabetes mellitus: A cohort study”	24
Severe hypertriglyceridemia and its correlation with clinical atherosclerosis and pancreatitis investigated in beta-quantification	24
Bempedoic acid efficacy and safety in 7,597 non-diabetic patients, with and without metabolic syndrome, from the randomized, placebo-controlled clear outcomes trial	24
Statin treatment reduces long-term risk of revision surgery following total hip arthroplasty in osteoarthritis patients: A registry-based study	23
The effect of MMP 9, TIMP-1 on the dynamics of cardiac fibrosis in patients with and without coronary artery disease 2 years after renal denervation	23
Dissecting sexual dimorphism in aortic valve stenosis by proteomics	23
Circulating monocyte phenotype: A novel biomarker of atherosclerosis	23
miR-148a-3p: A novel therapeutic candidate modulating angiogenesis and senescence for enhanced myocardial infarction recovery – experimental insights and targets explored	23
Machine-learning-based models to predict atherogenic index of plasma range using oculomics and clinic variables in KNHANES for assessing the risk of cardiovascular disease	23
The value of a negative study	22
Comorbidities, frailty, and prognosis in elderly patients with atrial fibrillation and ischemic heart disease: Insights from a tertiary hospital cohort study	22
Sex differences in the treatment of familial hypercholesterolemia: A systematic review and meta-analysis	22
The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia	22
Coronary artery calcium: The canary in the coal mine	22
Risk factors for progressive cardiorenal syndrome in patients with chronic kidney disease: The CRIC study	22
Statin therapy and lipoprotein(a) levels: A systematic review and meta-analysis	22
The comparative analyses of combined medicine alpha-lipoic acid and zinc with statins in the treatment of dyslipidemia in patients with atherosclerosis	22
Rare variants in U2-spliceosome genes are involved in autosomal dominant hypercholesterolemia	22
Residual risk in coronary artery disease: Insights from an observational study	22
Beyond quantity: The nonlinear association between HDL cholesterol and coronary atherosclerosis	21
Corrigendum to “The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities” [Atherosclerosis 381 (2023) 117247]	21
Metabolomics of aortic valve stenosis: Are aortic valve stenosis and sclerosis different diseases?	21
Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia	20
Gene set analysis of transcriptomics data identifies new biological processes associated with early markers of atherosclerosis but not with those of osteoporosis: Atherosclerosis-osteoporosis co/multi	20
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study	20
Lp(a) in Argentina: A multicenter study on prevalence and clinical outcomes	19
Repeated measurement of lipoprotein(a): technical versus biological variability	19
Editorial Board	19
Galectin-9: A novel promoter of atherosclerosis progression	19
Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation	19
Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study	19
Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program	19
Editorial Board	19
Circular decoys sponge miR-21 and miR-146a in senescent vascular cells	19
Fgf23 expression increases atherosclerotic plaque burden in male ApoE deficient mice	18
Sex differences in LDL-C control in a primary care population: The PORTRAIT-DYS study	18
NOD1 ligand FK565 promotes atherogenesis and accumulation of NOD1+ smooth muscle cells in atherosclerotic lesions	18
Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack	18
Interplay between epigenetic mechanisms and transcription factors in atherosclerosis	18
Hepatic Cdkal1 deletion regulates HDL catabolism and promotes reverse cholesterol transport	18
Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence	18
Possible clinical usefulness of polygenic risk scores among patients with established atherosclerotic cardiovascular disease	18
Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes	18
Exercise training-induced plaque stabilization in rabbits associated with restored β2-adrenergic receptor signaling and reduced ectopic trypsin	18
LAUNCHOF THE FIRSTHOFH AWARENESS DAY: ADDRESSING UNMET NEEDS	17
N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus	17
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)	17
Effect of biological sex on human circulating lipidome: An overview of the literature	17
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials	17
ESTABLISHMENT OF ELISA SYSTEM FOR MODIFIED LDLADIPONECTIN COMPLEX	17
Haemodynamic and blood viscosity profiles of culprit vs. non-culprit coronary vessels: Insights from NIRS-IVUS and CFD analysis	17
Bivariate relation of vascular health and blood pressure progression during childhood	17
Editorial Board	17
COMPUTATIONAL IDENTIFICATION OF SMALL MOLECULES FOR MODULATING ATHEROSCLEROSIS AND NAFLD	17
Differential associations of constituents of ambient fine particulate matter with 12 cardiovascular diseases: A prospective study	17
Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction	17
FIRST TIME USE OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, UAE	16
UCSCS IN TREATMENT OF T1DM AND T2DM; A META-ANALYSIS	16
CARDIO-PROTECTIVE ROLE OF ROSMARINIC ACID ON ISOPRENALINE INDUCED CARDIAC DYSFUNCTION	16
Repurposing statin treatment for the prevention of gallstone disease	16
A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis	16
Lysosomal acid lipase (LAL) deficiency alters immune cells distribution in mice and humans	16
METABOLOMIC ANALYSIS OF KAZAKH PATIENTS WITH METABOLIC SYNDROME BY GC/MS	16
Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH)	16
Diet quality, front-of-pack labeling, and lipoprotein particle profiles	16
Minigene splicing reporter assay: a high-stake tool for genetic diagnosis in familial hypobetalipoproteinemia	16
Inflammation in COVID-19 is linked to pulmonary embolism and/or vascular tree-in-bud in hospitalized patients. The university hospital of Ioannina COVID-19 Registry, NCT05534074	16
ACCURACY OF TROPONIN VALUE IN ELDERLY WITH ACUTE CORONARY SYNDROME	16
GENETIC AND BIOCHEMICAL ANALYSIS OF FOUR JAPANESE SEVERE HYPERTRIGLYCERIDEMIA	16
Lipoprotein(a) and cardiovascular disease: Make use of the knowledge we have	16
Reply to: “Longitudinal studies assessing retinal vascular characteristics in childhood and adolescence must account for ocular growth”	16
A novel homozygous variant in GPIHBP1 and familial chylomicronemia syndrome in latin America	16
Outcome of severe hypertriglyceridemia in hospital practice. A single centre experience from Singapore	16
Management of hypercolesterolemic subjects at high cardiovascular risk with PCSK9 inhibitors: A “real life” experience in a lipid clinic in sicily	15

Lipoprotein(a) is a predictor of atherogenesis in patients with COPD	15
Predictors of functional and morphological arterial wall properties in patients with increased lipoprotein (a) before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors	15
Dyslipidemia and other metabolic alterations in COPD as well as cardiovascular risk in a latin American hospital.	15
Low dose interleukin 2 expands plasmablasts with a regulatory b cell phenotype post-MI	15
Lifestyle and rate of metabolic risk factors in Norwegian patients with a severe mental illness	15
The polycomb repressive complex 2 (PRC2) in macrophages and atherosclerosis	15
The interplay between lipoprotein(a) and inflammatory markers in atherosclerotic cardiovascular disease (ASCVD): A focus on neutrophil-to-lymphocyte ratio (NLR)	15
LIPC-E97G gain-of-function variant protects from dyslipidemia and atherosclerosis in mice independently of the LDL receptor	15
Analysis of total cholesterol and its association with blood pressure, age and northern experience in men 25-54 years working on rotational shifts in the north	15
The role of antioxidant intake in weight status of children in early adolescence	15
LDL drives the polarized endothelial secretion of fibronectin through syntaxin-4 and syntaxin-6	15
Variant-specific LDL-cholesterol patterns and risk of atherosclerotic cardiovascular disease in heterozygous FH: Insights from the Austrian FH-Registry	15
The role of antiphospholipid antibodies in the onset of myocardial infarction	15
Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity	15
Post-prandial analysis of fluctuations in the platelet count and platelet activity in patients with the familial chylomicronemia syndrome	15
Empagliflozin prevents human aortic smooth muscle cells damage induced by cholesterol	15
Association of blood lipid profile with 20-year (2002-2022) incidence of cardiovascular disease: The ATTICA study	15
Impact of circulatory microRNA-126 &122 in severity of coronary artery disease correlation with small dense LDL: A case control study	15
Validation of site-less strategies and long-distance drone-based delivery and collection system to promote access to innovative treatments for patients with rare or severe dyslipidemias	15
Gender disparities among contemporary patients with acute coronary syndrome: Data from CALLINICUS-hellas registry	15
Myeloid cannabinoid receptor CB1 deficiency limits macrophage proliferation and atherosclerosis in a sex-specific manner	14
Protective effect of niclosamide on calcification of aortic valve interstitial cells and its underlying molecular mechanism	14
Cardiopulmonary exercise test alterations in young smokers with obesity	14
Treatment of vulnerable plaque using combined high-density lipoprotein and pentostatin- loaded microbubbles- mediated shock wave sonoporation therapy: Evaluation with positron emission tomography imag	14
Plasma concentrations of apolipoproteins and incident cardiovascular diseases in patients with type 2 diabetes	14
VEGF-A levels and G634c gene polymorphism as a predictor of adverse outcomes in patients with STEMI	14
Heteroplasmy of atherosclerosis-associated mitochondrial DNA mutations and its effects on respiration and viability of cybrids	14
High and low levels of serum Sirtuin6 in patients with acute ischemic stroke	14
The patient will see you now: Patient preferences for lipid clinic reviews in a COVID era	14
Chronic kidney disease induced atherosclerosis: The regulatory role of mIR-26b	14
Diagnosis, treatment and cardiovascular outcomes in homozygous familial hypercholesterolaemia: A sex-specific analysis	14
Prevalence and prognostic impact of lipid goal attainment and patient adherence to lowering lipid treatment: Data from community Italian setting	14
Genetic variation in ADAMTS13 are related to vWF levels, atrial fibrillation and cerebral ischemic events	14
Investigation of the antioxidant and anti-inflammatory potency of Echinacea angustifolia extract	14
The ceramide- and phosphatidylcholine- based coronary event risk test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes	14
The condition of the main arteries in patients with chronic heart failure and diabetes mellitus	14
Epicardial adipose tissue and metabolic markers in dominican type 2 diabetics with preserved cardiac function	14
An innovative berberine formulation is able to improve bbr bioavailability and the lipid and glycemic profile in HFD-fed mice	14
Arterial stiffness and glycometabolic control in older patients with type 2 diabetes	14
Orbital ischemia syndrome in a patient with carotid artery dissection - Case report	14
The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer	14
Response of lipoproteins to a meal tolerance test in patients with type 2 diabetes and hypertriglyceridemia	14
Mature natural killer type 2 cells and experimental atherosclerosis	14
Association of self-reported health and wellbeing indicators with a positive diagnosis for COVID-19. CARTSESIAN-CY study	14
Statin intolerance: What are we overlooking?	14
Nutritional approach in paediatric patients with familial hypercholesterolaemia	14
Polymorphism of DNA repair genes (APEX1 T444G RS1130409) in obese gout patients in the male population of the trans-baikal territory in Russia	14
In patients with cardiovascular disease and heart failure dental state (tooth loss) may exacerbate inflammatory syndrome	13
P-selectin as a modulator of fibrin clot properties in patients treated with high-dose statins	13
Dietary pattern of elderly people living in the rural area of Mortugaba (BA), Brazil	13
Frequency of variants causing familial hypercholesterolaemia (FH) and impact on LDL-C concentration in individuals of South Asian and African ancestry in the UK Biobank	13
Double trouble: Pathogenic LDLR and SCARB1 variants in the same family	13
The importance of cascade screening of familial hypercholesterolemia in routine clinical practice	13
Ensemble machine learning for screening cardiovascular diseases in electronic health records	13
Region-specific lipid markers of human carotid atherosclerosis plaque outcome detected by matrix-assisted laser desorption/ionization mass spectrometry imaging	13
Polymorphic assessment of proprotein convertase subtilisin/kexin type 9 (PCSK9) variant rs11591147 in coronary artery disease subjects from Pakistan	13
LPA genotypes and haplotypes influence lipoprotein(a) levels but not arterial wall properties, in stable post-coronary event patients with very high lipoprotein(a) levels	13
Pediatric reference values for non-fasting lipids in French-Canadian children	13
Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages	13
Small LDL subfractions are associated with coronary atherosclerosis	13
Positivity of statin-associated muscle symptoms – Clinical index in a hypertensive population candidated to lipid-lowering therapy but not taking statins	13
Granzyme B+ CD4+ T cells associate with an unstable plaque phenotype in advanced human atherosclerosis	13
Polygenic risk for future coronary artery disease events in familial hypercholesterolemia	13
Assessment of atherosclerotic lesions of the carotid arteries depending on the smoking index in patients with coronary artery disease	13
Associations of carotenoids, vitamin A and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study	13
Association of parental obesity and body mass index in children of patients with early ischemic heart disease	13
Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey	13
New method of calculating low density lipoprotein cholesterol using Korea National Health and Nutrition Examination Survey (KNHANES) and its validation	13
Protein alterations in VSMCS reveal a defective repairment capacity in thoracic aortic aneurysm associated to BAV	13
Increased values in total cholesterol and LDL cholesterol in “prediabetic” middle-aged and elderly adults with A1C between 5.7 and 6.4%	12
Optimization and validation of lipoprotein(a) KIV2 isoform measurement in patients with familial hypercholesterolemia	12
An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia	12
Splenic TFH cell localisation in atherosclerosis	12
Insights into homozygous familial hypercholesterolemia in Portugal	12
Alternative LDL cholesterol-lowering strategy versus high-intensity statin strategy in patients with diabetes and ASCVD: An individual patient data meta-analysis from the racing and lodestar trials	12
Spring licenses srebp signaling and governs hepatic lipid metabolism and lipoprotein levels in mice and humans	12
Treatment effects of ezetimibe in cholesteryl Ester storage disease	12
Infectious agent as a trigger mechanism of atherosclerosis and сerebrovascular diseases	12
Protective role for body fat mass in atherogenesis among low cardiovascular risk patients	12
Effect of Lipoxin-A4 on the glucose challenged monocyte-macrophage axis in early diabetes-associated atherosclerosis	12
Genotypic and phenotypic risk factors for atherosclerotic vascular disease in children with familial hypercholesterolemia	12
Long-term metabolic effect of the E97G gain-of-function variant of hepatic lipase in high-fat diet fed C57BL6/J mice	12
Does carotid intima media thickness have a role in predicting genetic familial hypercholesterolaemia?	12
Lipid profile and lipoprotein (a) in systemic sclerosis: A systematic review and meta-analysis	12
Pemafibrate induces atheroprotection in LDLR deficient mice through hepatocyte transrepression PPARA activity	12
Evidence of proatherogenic inflammation in vascular endothelium of caviae porcellous infected with helicobacter pylori and exposed to high fat diet	12
Atherosclerosis burden correlates with acquired pain sensitivity in diversity outbred mice	12
Vascular wall damage in atherosclerotic cardiovascular disease; Positive effect of extracellular vesicle-based nanotherapeutics on endothelial dysfunction and its key molecular players	12
Individuals with type 2 diabetes have increased coronary plaque burden and plaque progression during 10-year serial coronary CT angiography follow-up	12
Sex differences in atherosclerosis lesions and in the response to RAS inhibition in the ApoE-/- MICE	12
Impact of endothelial dysfunction on prognosis of coronary heart disease patients	12
Comparative efficacy and safety of different RNA interference therapeutics in the management of hypertension: A systematic review and network meta-analysis of clinical trials	12
Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35–75 years: Results from China PEACE Million Persons Project	11
The use of seaweed-derived phytosterols to defeat Alzheimer's Disease	11
Impact of ultrasound reverberation in calcified coronary arteries: Intravascular ultrasound study	11